Dawn Hershman, MD
Enriched profileWitten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology · Columbia University Irving Medical Center
Dawn Hershman is Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology at Columbia University Irving Medical Center. OpenAlex indexes 1,278 publications with 42,795 citations (h-index 103); ClinicalTrials.gov lists 23 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.
Data verified 21 Oct 2026
Overview
Updated 23 Oct 2026
Dawn Hershman, M.D., is Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology at Columbia University Irving Medical Center. The public record shows 1,278 publications with 42,795 citations (h-index 103), centered on Cancer survivorship and care, Breast Cancer Treatment Studies, Endometrial and Cervical Cancer Treatments. It also documents an investigator role on 23 registered clinical trials, industry payments reported by 7 companies, 14 NIH-funded awards (2002–2026).
- Top research focus: Cancer survivorship and care
- 23 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 65 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 501.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 23 registered studies on ClinicalTrials.gov. The most recent:
- Opioid Dispensing Device for Post-Operative Pain in Cancer Patients
Sponsor: Columbia University
- IMPACT Trial: Intervention to iMProve AdherenCe Equitably
Sponsor: Columbia University
- Video Consultation to Reduce Drug Interactions Among Patients Initiating Oral Anti-Cancer Drugs
Sponsor: Columbia University
Industry payments
Updated 23 Oct 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- LEICA MICROSYSTEMS INC.Program year20251 payment
- TerSera Therapeutics LLCProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
87.8%Aromatase Inhibitor81.3%Anastrozole83%Letrozole9%Exemestane8%Part D<11 patientsEstrogen Agonist/Antagonist6.5%Tamoxifen Citrate100%Part D<11 patientsNervous system
4.8%Phenothiazine4.8%Prochlorperazine Maleate100%Part D<11 patientsMetabolism & gastrointestinal
3.7%Serotonin-3 Receptor Antagonist3.7%Ondansetron Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 23 Oct 2026
14 NIH research awards on record, funded 2002–2026 per NIH RePORTER. The latest:
- SWOG Network Group Operations Center of the NCTN
University of California at Davis
FY2026$10,929,371U10CA180888 - CUIMC Calabresi Clinical Oncology Career Development Program
Columbia University Health Sciences
FY2026$895,145K12CA279872
Congress activity
Updated 23 Oct 2026
278 congress contributions (2004–2026) across AACR, ASCO, ASH, ASTRO, ESMO, SABCS per OpenAlex. The most recent:
- A risk prediction model for severe, life-threatening, and fatal treatment-related toxicity.
ASCO Annual Meeting
ASCO2026Co-author - Associations between self-efficacy and symptom burden in young women with breast cancer initiating endocrine therapy (ET) on SWOG S2010.
ASCO Annual Meeting
ASCO2026Co-author - Barriers and facilitators to implementation of evidence-based depression and distress treatment in adult oncology: A systematic review.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Most-cited works
by citation count (OpenAlex)- 01Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyArticle1,726 citations2020
- 02
- 03
- 04Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO GuidelineArticle1,043 citations2021
- 05
Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Albert Einstein College of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →publichealth.columbia.edu ↗ - MS (Biostatistics)
Mailman School of Public Health, Columbia
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →publichealth.columbia.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
Editorial & leadership roles
journal and society appointments- Editorial board member
Journal of Clinical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →publichealth.columbia.edu ↗ - Associate Editor
Journal of the National Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →publichealth.columbia.edu ↗ - Chair
Grants Selection Committee, ASCO
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →publichealth.columbia.edu ↗ - Chair
ASCO Quality Care Symposium
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →publichealth.columbia.edu ↗ - Vice Chair
SWOG Cancer Research Network
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →publichealth.columbia.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- Advanced Clinical Research Award in Breast Cancer
American Society of Clinical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →publichealth.columbia.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →publichealth.columbia.edu ↗
- Alpha Omega Alpha
Albert Einstein College of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
Media & interviews
press, podcasts and appearances- Breastcancer.org podcast (Spanish-language)
Clinical Trials Part 2, with host Jamie DePolo
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →breastcancer.org ↗ - Komen More Than Pink podcast
survivorship episode
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →realpink.komen.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fox5ny.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Rebecca Hahn, MD
Columbia University Irving Medical Center
Susheel Kodali, MD
Columbia University Irving Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center
Lawrence Honig, MD
Columbia University Irving Medical Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Eric Winer, MD
Yale School of Medicine
Norman Wolmark, MD
University of Pittsburgh
Hope Rugo, MD
City of Hope